Paradigm Biocapital Advisors LP Iovance Biotherapeutics, Inc. Transaction History

Paradigm Biocapital Advisors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$6.38 - $18.33 $5.79 Million - $16.6 Million	-907,428 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $785,176 - $1.21 Million	63,423 Added 7.51%	907,428 $15.1 Million
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $14 Million - $23.3 Million	844,005 New	844,005 $16.1 Million

323

239M

1.27M

1.68M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.52B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Paradigm Biocapital Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Paradigm Biocapital Advisors LP with notifications on news.